Ensuring Effective Pharmacovigilance Regulatory Intelligence

Pharmacovigilance (PV) is essential for the development and commercialization of drugs and medical devices, ensuring their safety and efficacy throughout their lifecycle. Effective PV regulatory intelligence (RI) is critical for the accurate and cost-effective execution of PV activities, holding significant importance for all stakeholders in the industry. Discover the strategies deployed by an increasing number of pharmaceutical, biotech, and medical device companies to ensure comprehensive and cost-effective PV RI in this new white paper. It delves into the key PV RI capabilities that drug developers should focus on, including:

• Monitoring regulation changes
• Analyzing and interpreting regulations and guidance
• Communicating regulatory requirements and operationalizing change
• Providing guidance on new and updated regulations
• Leveraging functional service provider (FSP) partnerships

Gain valuable insights into these strategies and more by reading the white paper.